Aconitum nap Fear Homeopathic Medicine Recalled for Failed Identification Testing
Washington Homeopathic Products is recalling Aconitum nap Fear homeopathic medicine nationwide due to out-of-specification test results from identification testing. The recall affects 562 bottles across multiple potencies and lot 26198.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a testing failure without reported illnesses or injuries. The source states only that identification testing produced out-of-specification results; no adverse health events or safety hazard is explicitly described or implied.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Aconitum nap Fear homeopathic medicine in the following formulations: 5X, 7X, 18X, and 30X potencies packaged in 30 mL containers, and 24X potency packaged in 50 mL containers. All affected products contain 87% alcohol and are identified as WHP Homeopathic Medicine.
The recall was initiated because identification testing conducted via HPTLC (high-performance thin-layer chromatography) analysis produced out-of-specification results. This means the product did not meet the required standards for identification verification.
A total of 562 bottles from lot 26198 were distributed nationwide in the USA. Consumers who have purchased this product should stop use and contact Washington Homeopathic Products, Inc. for further instructions regarding the recalled product.
The recalled product
- Product
- Aconitum nap Fear* 87% Alcohol HPUS: 5X, 7X, 18X, 30X, packaged in 30 mL containers, Aconitum nap Fear* 87% Alcohol HPUS: 24X, packaged in 50 mL containers, WHP Homeopathic Medicine, Washington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- failed-identification-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 26198
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27